AKR1B1 as a Prognostic Biomarker of High-Grade Serous Ovarian Cancer

SIMPLE SUMMARY: We evaluated the levels of AKR1B1 and AKR1B10 in 99 patients with high-grade serous ovarian cancer and their association with clinicopathological characteristics, survival, and response to chemotherapy. An immunohistochemical analysis showed that higher AKR1B1 levels correlated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Hojnik, Marko, Šuster, Nataša Kenda, Smrkolj, Špela, Sisinger, Damjan, Grazio, Snježana Frković, Verdenik, Ivan, Rižner, Tea Lanišnik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834204/
https://www.ncbi.nlm.nih.gov/pubmed/35159076
http://dx.doi.org/10.3390/cancers14030809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834204/
https://www.ncbi.nlm.nih.gov/pubmed/35159076
http://dx.doi.org/10.3390/cancers14030809

Ejemplares similares